Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation

International Journal of Clinical Practice

Volumn 59, Issue 12, 2005, Pages 1395-1400

  Zhang, N ^a   Guo, Jihong H ^a   Zhang, H Ch ^a   Li, X B ^a   Zhang, P ^a   Xu, Y ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Atrial fibrillation; Cardioversion; Ibutilide; Intravenous injection; Propafenone

Indexed keywords

IBUTILIDE; PROPAFENONE; ANTIARRHYTHMIC AGENT; SULFONAMIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUS RHYTHM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VOMITING; COMPARATIVE STUDY; DOSE RESPONSE; EPIDEMIOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT OUTCOME;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROPAFENONE; SULFONAMIDES; TREATMENT OUTCOME;

EID: 33646835397     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2005.00705.x     Document Type: Article

References (23)

1. Das MK, Cheriparambil K, Bedi A et al. Cardioversion of atrial fibrillation with ibutilide: When is it most effective. Clin Cardiol 2002; 25: 411-5.
2. Zhou ZQ, Hu DY, Chen J et al. An epidemiological survey of atrial fibrillation in China. J Intern Med 2004; 43: 491-4.
3. Volgman AS, Stambler BS, Kappagoda C et al. Comparison of intravenous Ibutilide versus procainamide for rapid termination of atrial flutter or fibrillation. PACE 1996; 19: 608.
4. Vos MA, Golitsyn SR. Stangl K et al. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Heart 1998; 79: 568-75.
5. Bernard EO, Schmid ER, Schmidlin D et al. Ibutilide versus amiodarone in atrial fibrillation: A double-blinded, randomized study. Crit Care Med 2003; 31: 1031-4.
6. Geelen P, O'Hara GE, Roy N et al. Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. Am J Cardiol 1999; 84: 345-7.
7. Ganau G, Lenzi T. Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: A randomized placebo-controlled multicenter trial. FAPS Investigators Study Group. J Emerg Med 1998; 16: 383-7.
8. Stroobandt R, Stiels B, Hoebrechts R. Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. Am J Cardiol 1977; 79: 418-23.
9. Bianconi L, Boccadamo R, Pappalardo A et al. Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset. Am J Cardiol 1989; 64: 335-8.
10. Kochiadakis GE, Igoumenidis NE, Simantirakis EN et al. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: A placebo-controlled study. PACE 1998; 21: 2475-9.
11. Reimold SC, Maisel WH, Antman EM. Propafenone for the treatment of supraventricular tachycardia and atrial fibrillation: A meta-analysis. Am J Cardiol 1998; 82: 66N-71N.
12. Suttorp MJ, Kingma JH, Jessurun ER et al. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990; 16: 1722-7.
13. Donovan KD, Power BM, Hockings BE et al. Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 1995; 75: 693-7.
14. Ellenbogen KA, Stambler BS, Wood MA et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response study. J Am Coll Cardiol 1996; 28: 130-6.
15. Sanfilippo AJ, Abascal VM, Sheehan M et al. Atrial enlargement as a consequence of atrial fibrillation. Circulation 1990; 82: 792-7.
16. Danias PG, Caulfield TA, Weigner MJ et al. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 1998; 31: 588-92.
17. VanderLugt JT, Mattioni T, Denker S et al. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation 1999; 100: 369-75.
18. Volgman AS, Carberry PA, Stambler BS et al. Conversion efficacy and safety of intravenous ibutilide and compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 1998; 31: 1414-9.
19. Bartoli P, Bonechi F, Brandinelli A et al. Efficacy of intravenous and per oral propafenone in the ambulatory treatment of recent onset atrial fibrillation. G Ital Cardiol 1992; 22: 257-65.
20. Vanderlut JT, Gaylor SK, Wakefield LK et al. Effects of ibutilide fumarate, a new class III antiarrhythmic agent in man. Clin Pharmacol Ther 1991; 49: 188-92.
21. Fresco C, Proclemer A, Pavan A et al. Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo-con trolled, double-blind, multicenter clinical trial. Clin Cardiol 1996; 19: 409-12.
22. Stambler BS, Beckman KJ, Kardish AH et al. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function. Am J Cardiol 1997; 80: 458-63.
23. Oral H, Souza JJ, Michaud GF et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 1999; 340: 1849-54.